Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03295734 · ClinicalTrials.gov registry record · Phase 2
ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension
A Phase 2 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 2
- Development phase
- 223
- Enrollment target
NCT03295734: Completed Phase 2 study, sponsored by University of Alabama at Birmingham.
NCT03295734 is a Phase 2 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 223 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (68% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03295734, a Phase 2 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 223 participants
- Enrollment target
Study Summary
The purpose of this project is to conduct a randomized, controlled trial (RCT) to determine if choice of antihypertensive medication influences changes in functional status and other cardiovascular risk factors among older persons with hypertension when combined with physical exercise.
Primary Outcome
Self-paced gait speed over 4m distance; change from baseline to week 32
Interventions
- DRUG Losartan
- BEHAVIORAL Aerobic exercise
- DRUG Perindopril
- DRUG HCTZ
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2018-05-29 |
| Est. Completion | 2024-09-19 |
| Phase | Phase 2 |
What the finished NCT03295734 record still lists
NCT03295734 is an interventional study that assigns participants to a tested intervention. The registered 223 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (68% higher).
The record links to 0 conditions, and to 4 interventions - of which Losartan is the first listed.
NCT03295734 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03295734 about?
NCT03295734 is a clinical study titled "ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension". The purpose of this project is to conduct a randomized, controlled trial (RCT) to determine if choice of antihypertensive medication influences changes in functional status and other cardiovascular risk factors among older persons with hypertension when combined with physical exercise.
What is the current status of trial NCT03295734?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 223 participants. The study started on 2018-05-29. Estimated completion is 2024-09-19.
What interventions are being tested in trial NCT03295734?
The interventions under investigation include: Losartan (DRUG), Aerobic exercise (BEHAVIORAL), Perindopril (DRUG), HCTZ (DRUG).
Who is sponsoring clinical trial NCT03295734?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03295734's enrollment target sits among peer trials
223 274th of 2000 higher than 1,727 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06640803 · 223 participants · NA
Sacramento Clinical High Risk for Psychosis Stepped-Care Program
- NCT07175285 · 223 participants
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- NCT07205718 · 223 participants · Phase 1
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
- NCT02706561 · 224 participants · NA
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI